Neuroscience
Creutzfeldt-Jakob Disease
News being reported from several news agencies in Australia about concern over risk of disease transmission via contaminated surgical instruments. Here is a report by
The Australian:
Killer brain disease hangs over patients
Gosia Kaszubska
September 14, 2004
MORE than 1000 people have been warned they may been exposed to a rare and fatal brain disease through contaminated surgical instruments used at the Royal Melbourne Hospital since March last year.
The 1056 former patients face years of waiting to discover if they will develop Creutzfeldt-Jakob disease, an incurable illness that can lay dormant for decades.
Concerns arose when it was confirmed a man who underwent brain surgery at the hospital twice last year had died of CJD.
The hospital yesterday sent letters warning all patients who had undergone brain or spinal surgery in the past 18 months that there was an "extremely remote chance" the disease may have been transmitted through instruments used in their operations.
The hospital is destroying all 15,000 neurosurgical instruments and has begun sterilising its entire stock of 300,000 surgical instruments to a higher standard that usual, on the advice of the National CJD Incidents Committee.
Neurology director Stephen Davis said the hospital was taking an "extra conservative" approach by sterilising all instruments, even though they had not been used in operations on the CJD-affected patient.
It is believed to be the first time an Australian hospital has been forced to contact patients after confirming a case of CJD in a former patient.
[ ... read the full report ... ]
-
Business World: Biogen Idec, Elan, & Tysabri (natalizumab) (cont.)
Additional information in follow-up to this morning's Boston Globe report, from Bloomberg:Elan, Biogen Decline on Report of New Tysabri Illness June 2 (Bloomberg) -- Shares of Elan Corp. and Biogen Idec Inc. tumbled after a fourth possible case of...
-
Abstract Of The Day: Dementia
Starkstein SE, Garau ML, Cao A. Prevalence and clinical correlates of disinhibition in dementia. Cogn Behav Neurol. 2004 Sep; 17(3): 139-47.
School of Psychiatry and Clinical Neurosciences, University of Western Australia, and Fremantle Hospital, Fremantle,...
-
Introducing The New Penn Neuroscience Center
On February 23, 2015, the Penn Neuroscience Center officially opened, with the mission of providing a new level of specialty care for those suffering from or at risk for complex neurological disorders. The outpatient facility joins together our neurology,...
-
Question And Answer With Dr. Ozturk
Ali K. Ozturk, MD, is Assistant Professor in the Department of Neurosurgery and sees patients at Pennsylvania Hospital and Penn Medicine Woodbury Heights. He specializes in the treatment of complex spinal conditions including tumors, degenerative spine...
-
U.s. News & World Report Names Penn Neurosurgery Best In Region
For the 24th consecutive year, Penn Neurosurgery has been ranked as best in the Philadelphia region, according to the U.S. News & World Report rankings released earlier this month. The specialty was also ranked 9th in the nation. In addition,...
Neuroscience